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ABSTRACT
Objective: The present study is undertaken to study the ameliorative effects of ethanolic extract of Mimosa pudica root (EMPR) on stress-induced 
anxiety and depressive-like behavior in Swiss albino mice.
Methods: The animals were subjected to acute restraint stress (ARS) for 7 days, and on the 8th day after drugs administration, the antianxiety effect 
was evaluated using elevated plus maze (EPM) test. Antidepressant activity was evaluated by animal despair models-forced swim test and tail 
suspension test. Phytochemical analysis of the extract was also conducted.
Results: EMPR (1000 and 2000 mg/kg) and the combined test groups have shown significant antianxiety effects similar to the standard diazepam as 
indicated by an improved open arm exploratory behavior in EPM model. EMPR also significantly reduced the immobility time in the animal despair 
models tested.
Conclusion: Results suggest that EMPR possesses significant anxiolytic and antidepressant activity in male Swiss albino mice.
Keywords: Depression, Anxiety, Elevated plus maze, Mimosa pudica root.
INTRODUCTION
Stress, which is a crucial element of existing health-care society 
and disease, also plays a significant role in the pathogenesis of 
neuropsychiatric disorder as these stressful events result in 
altered visceral, physiological, immunological, psychological, and 
neurobehavioral responses such as anxiety, depression, cognitive 
impairment, insomnia, anorexia, and activation of human hypothalamic-
pituitary-adrenal axis in animals and human [1,2]. Pernicious 
consequence on cellular effects, as a result of stressful conditions, arises 
due to disturbance in the balance between the production of reactive 
oxygen species and antioxidant defense mechanisms, which has also 
been shown to play a role in the pathogenesis of neuropsychiatric 
disorders [3-5]. Furthermore, preclinical studies have demonstrated 
that inhibition of oxidative stress may contribute to the therapeutic 
effect of some antidepressants [6-9]. Central nervous system (CNS) 
is mainly susceptible for damage by free radicals as the brain has 
abundant lipid content and requires more oxygen along with the 
comparative paucity of antioxidant enzymes [10].
Restrain stress can induce a series of dysfunction in CNS, such as 
cognitive impairment, anxiety, depression, amnesia, and insomnia [11], 
and it can also alter the free radical scavenging enzymes in discrete 
regions of the brain [12]. Hence, close surveillance was paid to study the 
protective effects of natural products on stress-induced injury in animal 
models. In this regard, numerous indigenous medicinal plants, which 
were once used as nerve tonics due to their adaptogenic and rejuvenating 
properties in ancient traditional medicine, have been investigated. The 
drugs of the plant origin are gaining increasing popularity and are 
being investigated for numerous neuropsychiatric effects including 
antidepressant, anti-stress, and adaptogenic activities [11-13].
Epidemiological studies have indicated a positive association between 
the consumption of phenolic-rich food or beverages and the prevention 
of diseases. These effects have been attributed to antioxidant 
components such as various phenolic acids like flavonoids and tannins 
among others.  Flavonoids, tannins, and phenolic components act as free 
radical scavengers and metal chelators, which are useful in preventing 
chronic disorders like cancer and neurodegeneration [14-16]. Roots of 
Mimosa pudica containing flavonoids, tannins, and steroid components 
may possess potential effects of anxiety and depression.
Abundant original medical plants which are safer and well tolerated are 
used since ages for treating neurological diseases including depression 
and epilepsy. M. pudica plant belonging to the family Fabaceae is known 
as “sensitive plant” in English and “lajvanti” or “chuimi” in local Hindi [17]. 
Previous studies on M. pudica have shown significant antiepileptic activity 
in its root part [18] and neuroprotective as well as anti-Parkinsonism 
activity of the whole plant extract [19]. However, so far no studies are 
reported about the beneficial effects of M. pudica linn roots in anxiety 
and depression induced by restraint stress. Considering substantial 
neuroprotective properties of M. pudica roots Linn., we sought to 
investigate the ethanolic extract of M. pudica root Linn. for its potential to 
improve cognitive impairment induced by ARS in adult Swiss albino mice.
METHODS
Plant materials and extraction
The fresh plant roots of M. pudica were collected during September–
October (2015) from Bannari forest (Dhimbam district), Coimbatore, 
Tamil Nadu. It was taxonomically identified and was authenticated by 
Dr. Mruthunjaya, Department of Pharmacognosy, JSS Pharmacy College, 
Mysuru, and herbarium of the plant is preserved for future references 
(Specimen Voucher No. 10601/Pharma). The collected roots were 
washed and shade dried at room temperature for 7 days. Dried roots 
were coarsely powdered and fine powder was separated. The coarse 
powder of roots (500 g) was subjected to extraction with ethanol by 
Soxhlet apparatus, and the extract was concentrated to dryness by 
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vacuum. The extract was then weighed to calculate the percentage 
of yield in terms of air-dried crude material. The resultant extract of 
Mimosa pudica root (EMPR) was kept in refrigerator for further use. 
Before administration, the extract was freshly prepared with normal 
saline, and two doses (1000 mg/kg and 2000 mg/kg) were selected 
based on the results of previous studies.
Animals
Adult male Swiss albino mice weighing between 22 and 30 g were 
randomly selected from the breeding stock of Central Animal Facility of 
JSS Medical College, Mysuru. They were housed in polypropylene cages 
under standard condition (25±3)°C, humidity 45%–55%, and 12/12 h 
light/dark cycle. They were given free access to food and water ad libitum. 
The animals were acclimatized for 7 days before the study. The study was 
conducted according to the Indian National Science Academy guidelines 
for the use and care of experimental animals. The experimental protocols 
were approved by the Institutional Animal Ethical Committee of JSS 
Medical College, Mysuru (JSSMC/PG/13B10601), and procedures in this 
study were performed in accordance with guidelines of the Committee 
for the Purpose of Control and Supervision of Experiments on Animals 
(261/PO/ReBi/2000/CPCSEA). All efforts were made to minimize 
animal suffering and the number of animals used in the experiments.
Experimental design
Thirty-six mice (n=6) were randomly divided into six experimental groups 
for evaluating the anti-anxiety effects in elevated plus maze (EPM). Groups 
I (control) mice received distilled water (1.0 ml/kg, p.o.) daily for 7 days; 
Groups II (Stress control) mice received distilled water (1.0 ml/kg, p.o.) 
daily for 7 days and subjected to restraint stress on the 8th day. Groups 
III (Standard) mice received diazepam (1mg/kg, i.p.), Groups IV and V 
received EMPR (1000 mg/kg and 2000 mg/kg, p.o., respectively), while 
Group VI was treated with combined dose of EMPR (1000 mg/kg p.o) 
+ standard (0.5 mg/kg, i.p.). All the drugs were administered daily for 
7 days, and the mice were subjected to ARS on the 8th day.
Depressive-like behavior was assessed by subjecting the mice 
to behavioral paradigms such as forced swim test (FST) and tail 
suspension test (TST).
Another set of thirty mice (n=6) was randomly divided into five 
experimental groups for FST and TST tests, and these animals were devoid 
of ARS procedure, which may otherwise interfere with the study. Group I 
(control) mice received distilled water (1.0 ml/kg, p.o), Group II (standard) 
mice received imipramine (15 mg/kg, i.p.), Group III and IV mice were 
treated with EMPR (1000 mg/kg and 2000 mg/kg; p.o., respectively), and 
Group V mice were treated with EMPR 1000 mg/kg (p.o.) + imipramine 
10 mg/kg (i.p.). The respective drugs were administered on 1st, 7th, and 
14th days for animals of each group. 60 min after the last dose of the drugs, 
the immobility period was recorded by both the models.
Chemicals
Ethanol, normal saline, imipramine, and diazepam (Sun 
Pharmaceuticals) were used.
Procedure for acute restraint stress (ARS)
ARS protocols were adapted from a previously described 
procedure [20]. Immobilization stress was accomplished by placing 
individual rodent on restraint device made of wire mesh for 4 h. This 
restrained all physical movements for the animals, and also they were 
deprived of food and water during the entire period of exposure to 
stress. After 4 h, the animals were released from their enclosure to their 
respective cages. On the 8th day, about 40-min post-release, the animals 
were subjected to behavioral tests. In normal control group, the mice 
were kept in their animal cages in the experimental room.
Behavioral assessments
EPM test
This test has been proposed for selective identification of anxiolytic or 
anxiogenic drugs. The EPM consists of two open arms and two enclosed 
arms sized 50×40×40 cm3 arranged to form a plus shape such that 
the two similar kinds of arms are opposite to each other. The maze is 
elevated to a height of 50 cm [21]. The EPM relies on rodents’ proclivity 
toward dark/enclosed spaces and an unconditioned fear of heights/open 
spaces [21,22].  After treatment with each group, the rats were placed in 
the center of the maze facing one of the enclosed arms. During the 5 min 
test period, the open arm exploration (for both entries and time) was 
calculated from number of open arm entries divided by the total number 
of entries in both open and closed arms and the time spent on open 
arm exploration divide by total time spent in both open and close arms, 
respectively. The procedure was conducted in a sound-attenuated room.
FST
The test was first described by Porsolt et al. (1977). A vertical glass cylinder 
(25 cm height and 14 cm in diameter) was filled with water of temperature 
27°C to a depth of 20 cm. Each mouse was gradually placed in the cylinder 
for 6 min and the duration of floating (i.e., the time during which mice 
made only the small movements necessary to keep head above water) was 
scored. Immobility time was analyzed during the past 4 min period of the 
test. Readings were taken on the 1st, 7th, and 14th days of treatment.
TST
The TST was conducted as previously described by Steru et al. (1985) 
with slight modification. Mice were suspended from the edge of a 
table 50 cm above the floor by an adhesive tape placed approximately 
1 cm from the tip of the tail. The total duration of immobility was recorded 
during the past 4 min of the 6 min test period. Mice were considered 
to be immobile only when they hung passively and were completely 
motionless. Recording of the duration of immobility in animals was done 
by an observer blind to the treatment given to the animal under study. 
Readings were taken on 1st, 7th, and 14th days of treatment.
Statistical analysis
The results were computed using GRAPH PRISM PAD version 7 
software, and one-way ANOVA test followed by Post hoc Dunnett’s 
multiple comparison tests was applied for analysis. Observations were 
expressed as means±standard error of mean. The differences between 




The freshly prepared EMPR was subjected to phytochemical screening 
tests for the detection of various active constituents. The extract 
showed the presence of flavonoids, tannins, and steroids in the crude 
extract of EMPR as depicted in Table 1.
Acute oral toxicity study
The acute toxicity was carried out in adult Swiss albino mice by fixed 
dose method of the Organization for Economic Cooperation and 
Development guideline No-423 [23]. Ethanolic extract of roots of 
M. pudica was given orally up to the dose level of 4000 mg/kg [24].
Table 1: Phytochemical screening of ethanolic EMPR
Sl. no Chemical constituents Test EMPR




2 Test for carbohydrates Molisch’s test -
3 Test for saponins Foam test -




5 Test for flavonoids Shinoda test +
6 Test for tannins Ferric chloride test ++
Gelatin test +
Phytochemical screening of the crude EMPR extract, EMPR - Ethanolic extract 
of Mimosa pudica roots, +: Present, −: Absent, ++: Reaction intensity is high, 
+: Reaction intensity is normal
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Behavioral studies
EPM
Analysis of EPM data revealed that ARS (4 h/6 consecutive days) in 
control stress group induced a significant reduction in the percentage 
of open arm entries and time spent in open arms as compared to the 
normal control group (p<0.05), while post-treatment with ethanolic 
EMPR (1000 and 2000 mg/kg) for 6 days reversed the restraint stress-
induced changes in both number of open arm entry and time spent 
in open arms as compared to the control stress group (p<0.01). Post-
EMPR treatment with 1000 mg/kg showed a significant increase in the 
time spent in open arm as compared to the control group., while there 
was a significant increase in both number of open arm entries and time 
spent in open arms indicating improvement in exploratory attitude and 
anti-anxiety activity among the animals treated with EMPR 2000 mg/kg 
and in combined group when compared to the control group (Table 2).
Table 2 shows the effect of pretreatment on ARS-induced changes in 
the EPM test.
FST
The mice treated with EMPR were also evaluated for depressive-like 
behavior elicited by forced or despair swim test. The immobility period 
during FST test was measured (Table 3). This immobility is known to 
reflect a state of depression in mice. In the FST, our results showed that 
the immobility time decreased significantly on the 1st, 7th, and 14th days 
in the group treated with the combined drugs (p<0.001). In test groups 
treated with EMPR (1000 mg/kg and 2000 mg/kg), a significant 
decrease in immobility period was observed on 7th and 14th days as 
compared to the control group (p<0.01) (Table 3).
In Table 3, the FST results show significant anti-depressive effects by 
EMPR.
TST
Mice treated with the standard drug imipramine (15 mg/kg) exhibited 
a highly significant decrease in the immobility period (p<0.0001) 
as compared to control group, whereas in EMPR test group, a 
significant decrease in immobility time was observed at the dose 
of 2000 mg/kg on days 7 and 14. However, in the combination test 
group (EMPR 1000 mg/kg+imipramine 10 mg/kg), the significant 
antidepressive effect improved from day 1 onward to day 14 as 
evidenced by the decrease in immobility period (p<0.01, p<0.001, and 
p<0.001 on 1st, 7th, and 14th days, respectively) (Table 4).
Table 4 presents that the TST results show significant antidepressive 
effect in EMPR 2000mg/kg and combination test groups. 
DISCUSSION
Stressful episode influences the non-specific response of the body 
to any demand imposed on it [25]. Stress is known to alter the 
physiological homeostasis of the organism and complex mechanisms 
contributing to the breakdown in adaptation processes, resulting in 
various visceral, endocrinal, and behavioral changes [1]. Stress also 
plays the major role in the pathogenesis of various mental disorders. 
Anxiety and depressive disorders in particular affect about 1/8th of 
the total population worldwide and have become one of the important 
research fields in psychopharmacology during this decade [26]. ARS 
type of stressful events has been reported to induce anxiety and 
Table 2: Effect of EMPR on EPM
Groups (n=6) Treatment Percentage of protection
Number of Open arm entries Open arm time (s)
I Control (distilled water) 20.4±0.8ns 10±1.15*
II ARS control (distilled water) 8.6±0.8 4.6±0.50
III Diazepam (1.5mg/kg) 36.8±1.3**** 23.6±1.2****
IV EMPR (1000mg/kg) 21.8±0.8ns 13.8±0.8*
V EMPR (2000mg/kg) 25.2±0.03** 14.6±0.5**
VI EMPR (1000mg/kg)+ Diazepam (1mg/kg) 26.6±0.5*** 16.4±0.8***
EMPR: Ethanolic extract of Mimosa pudica roots. Results are expressed as mean±SEM (n=6). Statistical test was performed by one-way ANOVA followed by post hoc 
Dunnett’s multiple comparison tests. ****p<0.0001, ***p<0.001, **p<0.01, *p<0.05. ns: Non-significant. EPM: Elevated plus maze
Table 3: Effect of EMPR on FST in mice
Groups (n=6) Drug treatment Immobility time (s)
Day 1 Day 7 Day 14
I Control (distilled water 1 ml) 130.3±2.3 137±1.5 141.2±0.6
II Imipramine (15 mg/kg) 97.1±2.3**** 96.5±3.2**** 83.3±1.8****
III EMPR (1000 mg/kg) 129.3±1.3ns 129.8±1.4** 134.3±0.17***
IV EMPR (2000 mg/kg) 129.8±0.3 ns 125.3±0.4**** 126.8±0.7****
V EMPR (1000 mg/kg)+ Imipramine (10 mg/kg) 118.8±2.5**** 116.5±0.7**** 114.5±1.5****
EMPR: Ethanolic extract of Mimosa pudica roots. Comparison was performed between control and all the other groups. Values expressed as mean±SEM. Statistical 
analysis is performed by one-way ANOVA followed by post hoc Dunnett’s multiple comparison test. *p<0.05, **p<0.01; ***p<0.001; ****p<0.0001; ns: Non significant
Table 4: Effect of EMPR on TST in mice
Groups (n=6) Drug treatment Dose (ml/kg or mg/kg) Immobility time (s)
Day 1 Day 7 Day 14
I Control (distilled water) 1.0 146.2±2.1 148.8±2.8 149.3±2.4
II Imipramine (15 mg/kg) 15 100.8±0.07**** 97.3±0.6**** 94.5±1.4****
III EMPR (1000 mg/kg) 1000 126.3±17.09ns 137.3±1.3ns 137.5±0.7ns
IV EMPR (2000 mg/kg) 2000 130.2±0.4ns 135.2±4.8* 124.2±2.3*
V EMPR (1000 mg/kg)+Imipramine (10 mg/kg) 1000+10 114.8±0.9** 115.3±1.1*** 113.3±2.3***
EMPR: Ethanolic extract of Mimosa pudica root. Test values compared to control group are expressed as mean±SEM. Statistical test is done by one-way ANOVA followed 
by post hoc Dunnett’s multiple comparison test, ns: Non significant, *p<0.05, **p<0.01; *** p<0.001
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depression-like behavioral models effectively. ARS is a reliable model 
for anxiety and depression induced by a mental stress produced due 
to a restraint or an inescapable state, in addition to impairment in the 
in vivo antioxidant defense mechanism [27].
Stress-induced behavioral alteration can be monitored in the rodent. EPM 
is the most commonly employed test to study the effect of anxiolytics on 
behavioral parameters of animals. In the present study, ARS (4 h) causes 
anxiety-like behavior and reduction in exploratory attitude as evidenced 
by a significant reduction in the EPM parameters such as the number 
of open arm entries and time spent in open arms. The results are in 
agreement with previous studies [28,29]. Increase in the percentage of 
open arm entries and the time spent in open arms of EPM following the 
treatment with EMPR at the two different dosage levels might be due to the 
chemical constituents present in it such as tannins, flavonoids, and others. 
The combination group with lower doses of EMPR and standard diazepam 
significantly increased the number of open arm entries and time spent in 
open arms almost comparable to a standard dose of drug diazepam.
EMPR extract reduced the duration of the immobility on the 1st, 7th, and 
14th days of readings in both the models of depression, namely, FST 
and TST in comparison with control and exhibited a dose-dependent 
effect. The characteristic behavior evaluated in these tests, termed as 
immobility, has been considered to reflect behavioral despair similar 
to that seen in the human depression, and hence, any reduction in 
this parameter reflects antidepressant activity. There is a significant 
correlation between the clinical efficacy of antidepressant drugs 
and their potency in FST which is not found in any other model. 
Furthermore, our data indicated that higher doses of plant extracts 
were more effective than smaller doses both in FST and TST.
Our study is in accordance with the previous study which demonstrated 
that ethyl acetate extract of leaves of M. pudica L in the dose up to 
400 mg/kg p.o. significantly alleviated the symptoms of anxiety, depression, 
and dementia in Swiss albino mice [27]. Another study also showed similar 
results of antidepressant and anxiolytic properties of the 100–500 mg/kg 
of lyophilized aqueous leaf extract of M. pudica in mice [28].
As a mentioned in the results, EMPR possesses various phytochemicals 
such as flavonoids, tannins, and steroids. CNS depressant and anxiolytic 
activity of EMPR reflected in results of the study may be attributed 
to these phytochemicals found in the extract. Several plants have 
been reported to have CNS depressant and anxiolytic activity due 
to the presence of flavonoids [29,30], tannins, saponins [30], and 
triterpenoids/steroids [29], from their phytochemical analysis. 
Phytochemical analysis of EMPR also revealed the presence of 
flavonoids, tannins, and steroids. Flavonoids, tannins, and triterpenoids 
are reported to have agonist/facilitatory activities at GABAA receptor 
complex, which led to hypothesis that they can act as benzodiazepine-
like molecules. This is supported by their behavioral effects in animal 
models of CNS depression and anxiety [31,32].
CONCLUSION
From the results obtained, we conclude that EMPR possesses 
significant CNS depressant and anxiolytic activity. Flavonoids, tannins, 
and steroids may be the phytochemicals responsible for this activity. 
Central antidepressant and anxiolytic activity along with significant 
antiepileptic activity as reported in our previous studies may 
complement each other and thus may be useful in the treatment of 
different types of epilepsy, depression, and anxiety-like conditions.
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